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Objectives: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused
devastation in over 200 countries. Italy, Spain, and the United States (US) were most severely
affected by the first wave of the pandemic. The reasons why some countries were more
strongly affected than others remain unknown. We identified the most-affected and lessaffected countries and states and explored environmental, host, and infrastructure risk factors
that may explain differences in the SARS-CoV-2 mortality burden.
Methods: We identified the top 10 countries/US states with the highest deaths per population
until May 2020. For each of these 10 case countries/states, we identified 6 control countries/
states with a similar population size and at least 3 times fewer deaths per population. We
extracted data for 30 risk factors from publicly available, trusted sources. We compared case
and control countries/states using the non-parametric Wilcoxon rank-sum test, and conducted
a secondary cluster analysis to explore the relationship between the number of cases per
population and the number of deaths per population using a scalable EM (expectation–
maximization) clustering algorithm.
Results: Statistically significant differences were found in 16 of 30 investigated risk factors,
the most important of which were temperature, neonatal and under-5 mortality rates, the
percentage of under-5 deaths due to acute respiratory infections (ARIs) and diarrhea, and
tuberculosis incidence (p < 0.05)
Conclusion: Countries with a higher burden of baseline pediatric mortality rates, higher
pediatric mortality from preventable diseases like diarrhea and ARI, and higher tuberculosis
incidence had lower rates of coronavirus disease 2019-associated mortality, supporting the
hygiene hypothesis.
Keywords: Coronavirus; Environment; Mortality; Public health

Introduction
By April 1, 2020, over 810,000 confirmed cases and 40,000 confirmed deaths were reported due
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to severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) globally [1]. In the initial stages of the pandemic
of coronavirus disease 2019 (COVID-19), which is caused
by SARS-CoV-2, the incidence and mortality rates varied
widely in different countries. Among the countries with
the highest incidence and mortality rates due to COVID-19,
certain populous countries such as the United States
(US), Brazil, and Mexico were particularly affected [1]. The
trajectories of COVID-19-specific mortality rates highlight
the discrepancies of the COVID-19 impact worldwide.
Within the US, New York City became the epicenter of the
US and was particularly hard-hit early. In the first month
following the confirmation of COVID-19, 130,689 cases were
identified and the mortality rate was 244 deaths per million.
In comparison, Pennsylvania, which has a comparable total
population size to New York City, had 28,685 confirmed
cases in the first month and a significantly lower mortality
rate, at 59 deaths per million [1]. Similar discrepancies were
noted across different countries such as Italy and France,
which have comparable population sizes; however, Italy
had 69,176 confirmed cases and 126 deaths per million
by the end of the first month, as reported by the World
Health Organization (WHO) [1], whereas France had 43,977
confirmed cases in the first month and a lower mortality
rate, at 45 deaths per million, within the same period [1].
Based on variations at the state, regional, and national
levels, as well as the beliefs of leaders, different policies and
practices were implemented to contain the pandemic with
varying success. The extent of the contribution of natural and
environmental factors to variation in the COVID-19 incidence
and mortality rates across different countries is unclear,
as is the contribution of various policies implemented by
countries and regions. Consequently, we estimated the
mortality rates in the first month of the pandemic for all
countries, as the total number of cases of COVID-19 is not yet
known given gaps in testing for COVID-19 as reported by the
WHO [1]. All countries were assessed in their first month of
the pandemic, and factors associated with high morbidity
and mortality were explored. This has implications because
it can provide insights into what makes a society vulnerable
to the rapid spread of COVID-19, with relevance for the future.
In particular, identifying the risk factors that contributed to
variation in mortality rates has important implications for
the second and third waves of the pandemic. A careful casecontrol analysis of contributors (including environmental,
natural, and policy differences) to the severity of disease
and mortality in COVID-19 was conducted to shed light on
discrepancies in the first wave of the pandemic globally.

https://doi.org/10.24171/j.phrp.2021.12.2.03

Materials and Methods
Cases and controls were selected by matching countries
with the highest COVID-19 mortality rates compared to
those with the lowest. Matching was done based on the
population size and WHO region (where possible). This
study covered the period between March and May 2020
to represent the first wave of the COVID-19 pandemic. We
shortlisted all countries that had at least 100 cases by March
31 (106 countries), as identified by Ritchie et al. [2]. We
referred to the day when a country reported its 100th case
as day X. For each country, we took the time of 1 month (30
days) after the day of the first 100 cases (day X). We referred
to this as day Y, whereby Y = X + 30 days. All further data
were obtained for day Y of each country, as identified by
Ritchie et al. [3]. All countries were arranged in descending
order by the total deaths/population in those 30 days, and
the top 10 countries were selected. For countries with an
area greater than 5,000,000 km2, the unit of comparison
was by state/province. These countries included Russia,
Canada, the US, Brazil, and Australia. The top 10 countries in
terms of COVID-19 deaths per population were selected for
analysis as cases. To select controls, countries and US states
were listed by decreasing order of population.
For each case, 6 controls were matched according to the
closest population size. Controls were selected based on 3
criteria: (1) the control countries were closest in population
size to the case country, (2) 2 controls were from the same
WHO region and 4 from different WHO regions, and (3) the
COVID-19 death rates per population of the controls were at
least 3 times lower than that of the case (Table 1, Figure 1).

Data Sources, Collection Process, and Tool
Based on 3 different contributors (the environment,
infrastructure, and host-related factors), potential risk
factors that may determine the severity of COVID-19 burden
in these 3 categories were shortlisted (Table 2). For each
variable, reliable sources of publicly available information
for all countries were utilized. Data were manually entered in
Microsoft Excel and a tool was utilized to process the data. A
complete list of sources is found in Table S1.
After piloting the data, 2 control countries (Taiwan and
Hong Kong) had many missing variables due to the nonavailability of data, and variables were treated as missing.
For 23 out of 30 variables, comparable data were not found
for states within the US (Table S1). Therefore, data available
for the entire country were used instead. For infrastructure
factors, data for public transportation were missing;
given high intercity variability, only the top metropolitan
city in the country was considered. Population size was

65

Global variation of COVID-19 mortality

Table 1. List of case and control countries/states
Same
WHO region controls

Case country/state

Different
WHO region controls

New Jersey

Tennessee

Indiana

Austria

Connecticut

Oklahoma

Utah

Kuwait

New York
Michigan
Louisiana
Spain
Belgium

Florida
Washington
Alabama
Uzbekistan
Czech Republic

Texas
Arizona
Kentucky
Poland
Greece

Australia
Jordan
Georgia
Argentina
Tunisia

United Arab
Emirates
Bosnia and
Herzegovina
Niger
Sweden
Slovakia
Iraq
Cuba

Italy
Netherlands
United Kingdom

Turkey
Romania
Germany

Ukraine
Kazakhstan
Russia

South Africa
Ecuador
Thailand

Colombia
Guatemala
Egypt

Hong Kong

Belarus

Moldova

Armenia

Sri Lanka
Portugal
New Zealand
Afghanistan
Dominican
Republic
South Korea
Cambodia
Philippines

Taiwan
Kyrgyzstan
Croatia
Algeria
Rwanda
Kenya
Senegal
Vietnam

WHO, World Health Organization.

All the countries that had at least
100 cases by Mar 31 (n = 106)
100th case day = day X

used to ascertain the top metropolitan city, and the public
transportation system of the selected cities was analyzed for
further analysis.

Data Analysis
Period Y = 30 days from day X
(Y = X + 30)

Total period Y deaths for each country was taken

Period Y deaths per population was calculated

Top 10 countries with highest period Y deaths per
population were selected
Countries with <1,000 deaths were excluded and
the next country was selected from the list

For each of the 10 countries selected, 2 controls were
selected from the same World Health Organization (WHO)
region and 4 controls from any other WHO region
The control country should have had 3 times less deaths
per population during their period Y

Temperatures in March and April were found separately,
using the arithmetic mean to obtain the average temperature
of March and April. Public transportation was divided into 4
categories: (1) none, (2) over-ground transport system only
(buses/trams), (3) underground mass public transport only,
and (4) over-ground and underground transport systems.
Data analysis was carried out in Stata 15.1 (StataCorp., College
Station, TX, USA), and Power BI (Microsoft Corp., Redmond,
WA, USA) was used for the graphics. Due to the skewed
distribution of variables, data were reported as median and
interquartile range. The non-parametric Wilcoxon ranksum test was used to compare factors between the 2 groups.
The cluster analysis was performed using a scalable EM
clustering algorithm, which iteratively refines an initial
cluster model to fit the data and determines the probability
that a data point exists in a cluster. The algorithm ends the
process when the probabilistic model fits the data. The
function used to determine the fit was the log-likelihood of
the data given the model.

Ethical Approval
Ethical approval was not required, as all information was
freely available in the public domain.

■

Cases: 10

■

Same region controls: 10 × 2 = 20

■

Different region controls: 10 × 4 = 40

■

Total: 10 + 20 + 40 = 70

Figure 1. Algorithm used to select case and control
countries/states.
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Results
Geographically, all cases were in the northern hemisphere;
5 were states within the US, whereas the other 5 were
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countries in Europe
(Figure 2).
Controls
were located across 6
All the countries
that
had at least
100 cases
by risk
Mar 31
(n = 106)
continents (Figure
2). The
factors
that were significantly
case
day = day
X
different in cases 100th
versus
control
countries/states
are given in
Figures 3 and 4; of the 30 risk factors that were investigated,
16 were found to be significant. Host-related factors were also
Period Y = 30 days from day X

observed to contribute to the difference in mortality rates
Top
with
highest period
Y deaths per
(Figures 5,
6).10Acountries
secondary
analysis
was conducted
to compare
population were selected
the number of cases and the number of deaths in period Y,
Countries with <1,000 deaths were excluded and
and the results
arecountry
shownwas
in Figure
Italy
and
the next
selected7.
from
the
list Spain had a
much higher proportion of deaths per reported cases than the
US. There were limited data for the case countries/states on

Table 2. Comparison of risk factors in case and control countries and states (significant factors only)
(Y = X + 30)

Risk factor

For each of the 10 countries
Case selected, 2 controls
p were
selected from the same WHO region and 4 controls
from any other WHO region
12.3 (4.1−20.8)The control country
5 (2.5−8.6)
0.035
should have had 3 times less
deaths

Control

Environmental factor
March temperature (°C)
April temperature (°C)
Average
(°C)for each country was taken
Total temperature
period Y deaths
UV light index (J/m²)
Host factor
Life expectancy at birth (y)
Under-5 mortality rate (/1,000 live births)
Neonatal mortality rate (/1,000 live births)
Period Y incidence
deaths per(/100,000
population
was calculated
Tuberculosis
population)
% of under-5 deaths due to diarrhea
% of under-5 deaths due to acute respiratory infection
Figure
1. of national BCG program
Presence
Infrastructure factor
Education index
Population density (people/km2)
Human Development Index
% of GDP on healthcare
Population of age ≥ 65 (% of total population)

15.3 (9.6−21.6)
13.5 (6.8−20.6)
3,230 (2,138−4,862)
75.2 (71.5−77.6)
10 (6−22)
6 (3−12)
26.5 (5.5−69.0)
1.7 (0.4−5.4)
1.0 (5.3−15.1)
42 (70)

per population
during their period Y0.013
8.1 (7.6−11.7)

6.6 (5.5−10.2)
1,662 (1,645−2,444)
■
■
■
■

0.69 (0.60−0.78)
90 (57−136)
0.77 (0.70−0.84)
6.8 (5.3−8.2)
12 (5−16)

0.023
0.008

81.410
(81.2−82.8)
0.040
Cases:
4 (3−4)
Same
region controls: 10 x 2 = 20 0.003
2 (2−2)region controls: 10 x 4 =0.008
Different
40
4.6 10
(2.3−8.0)
0.004
Total:
+ 20 + 40 = 70
0.3 (0.2−0.4)
1.8 (1.4−2.4)
0

0.81 (0.79−0.86)
275 (205−378)
0.92 (0.89−0.92)
9.6 (8.9−10.1)
18 (16−19)

0.016
0.002

< 0.001
0.012
0.017
0.003
0.014
0.001

Data are presented as medians (interquartile range) or n (%).
IQR, interquartile range; UV, ultraviolet; BCG, Bacillus Calmette-Guérin; GDP, gross domestic product.

Figure 2.

Figure 2. Map showing case and control countries/states.
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Host

Environment

Environment

◆

Temperaturea)

◆

Rainfall

◆

UV light penetrationa,b)
◆

Temperaturea)

◆

Rainfall

◆

UV light penetration

Host

◆

Life expectancya,b)

◆

Pediatric mortalitya,b)

◆

Deaths due to diarrheaa,b)

◆

a,b)

Infrastructure

a,b)
Life
expectancya,b)
Deaths due to ARI

◆

Educationa,b)

◆

Population densitya,b)

◆

Human Development Indexa,b)

◆

Health care expenditure◆a,b)Education

a,b)

◆

a,b)
◆ Population density
Pediatric mortalitya,b)Public transportation system

◆

Deaths due to diarrheaa,b)

◆

Obesity

◆

Stuntingb)

◆

Body mass indexb)

◆

Tobacco useb)

◆

Malariab)

◆

Tuberculosis ◆

◆

National BCG programa)

Figure 3.

Infrastructure

◆

◆
◆

Healthcare faciltiesb)

◆

WASH infrastructureb)

◆

Povertyb)

a,b)

◆

Deaths due to ARI

◆

Obesity
b)

Stunting

b)

◆

Human Development Indexa,b)

◆

Health care expenditurea,b)

◆

Public transportation system

◆

Healthcare faciltiesb)

◆

Body mass index

◆

WASH infrastructureb)

◆

Tobacco useb)

◆

Povertyb)

b)

◆

Malaria

◆

Tuberculosis

◆

10 a)
National BCG program

Figure 3. Three domains of risk factors studied.
a)

12
Case
Control

8
b)

Statistically significant differences noted between cases and controls. Individual State data was not available; therefore, data was
6
taken for whole of United States. UV, ultraviolet; ARI, acute respiratory infection; BCG, Bacillus Calmette-Guérin; WASH, water, sanitation,
and hygiene.
4

Figure 3.

Average temperature of March and April

2

12
Case
Control

10

Mortality rate

0
8

Under-5 mortality rate
(per 1,000 live births)

Neonatal mortality rate
(per 1,000 live births)

6

Figure 5.

0°C
10°C
20°C
30°C

Average temperature of March and April

Figure 4. 4. Map showing temperatures in included countries/
Figure
states.

4
2
0

Under-5 mortality rate
(per 1,000 live births)

Neonatal mortality rate
(per 1,000 live births)

Figure
Figure5.
5. Comparison of pediatric mortality rates in case
and control countries/states.

stunting, malaria incidence, and poverty.
0°C
Environmental
Factors
10°C

The case20°C
countries/states recorded lower average temperatures
in March
and April (6.6°C) than the controls within that period
30°C
(13.5°C, p =0.023) (Table 2). The ultraviolet (UV) light index
was lower in the case countries/states (1,662.0 J/m2) than in
Figure
4.
the
controls
(3,229.5 J/m2, p = 0.008) (Table 2).

Host-Related Factors
Among the host-related factors, pediatric and neonatal
mortality rates, causes of under-5 deaths, adult life expectancy,
and others were significantly different among the cases and
controls. The neonatal mortality rate was 2 per 1,000 live births in
the cases versus 6 per 1,000 live births in the controls (p =0.008)
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Acute
respiratory
infection
Case
Control

Diarrhea
0

2

4

6

8

10

12

Percentage of total under-5 deaths
Acute
respiratory
Figure
6. Comparison of top causes of under-5 deaths
infection

Figure
6. control countries/states.
case and
Diarrhea

in

Case
Control

(Table 2). The under-5 mortality rates were 4 and 10 per 1,000
0
2
4
6
8
10
12
live births in the cases and controls, respectively (p =0.003)
of total under-5 deaths
(Table 2, Figure 5). InPercentage
the case countries/states,
0.3% of under-5
Figure 6.
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10,000
Cluster 1
Cluster 2
Cluster 3
Cluster 4

No. of deaths till period Y

8,000

6,000

4,000

2,000

0

0

50,000

100,000

150,000

200,000

No. of cases in period Y

Figure 7. Comparison of number of deaths and number of cases in period Y in all included countries/states.
deaths were due to diarrhea, versus 1.7% in the controls (p =0.016)
(Table 2). Furthermore, 1.8% of all under-5 deaths in the case
countries/states resulted from acute respiratory infections,
versus 10.0% in the controls (p =0.002) (Table 2, Figure 6).
In the cases, the tuberculosis incidence was found to be 4.6 per
100,000 population, versus 26.5 in the controls (p =0.004) (Table 2).
National Bacillus Calmette-Guérin (BCG) vaccination programs
were not present in the cases, whereas 42 control countries/
states (70%) had these programs (p <0.001) (Table 2).

Infrastructure
The education index was 0.81 in the case countries/states
and 0.69 in the controls (p = 0.012), whereas the Human
Development Index was 0.92 versus 0.77 in the case and
control countries/states, respectively (p = 0.003) (Table 2).
The case countries/states spent 2.87% of gross domestic
product more than the control countries on healthcare, and
this was a significant difference (p = 0.014). The population
density was 3 times higher in the case countries/states than
in the controls (275 vs. 90 people/km2 of land area, p = 0.017)
(Table 2).

Discussion
The analysis of our data showed many interesting results.
The cases were all high-income countries in North America

https://doi.org/10.24171/j.phrp.2021.12.2.03

and Europe. There was a significant difference in living
standards between the case and control countries, with
the controls belonging to the low-income group (overall)
with poorer healthcare and education and higher mortality
from diarrhea and respiratory infections in childhood. Our
findings suggest that countries with poorer economies and
health systems did not experience worse outcomes in the
early stage of the COVID-19 pandemic.
The baseline mortality due to acute respiratory infections
was more than 5 times higher in the controls than in the
cases. Our findings suggest that young children, including
infants, who have a higher susceptibility and burden of
other respiratory infections, may have milder COVID-19
due to the long-term boost of the innate immune response,
known as trained immunity, as noted by Netea et al. [4]. The
case countries all had lower incidence rates of tuberculosis,
as well as no national BCG vaccination programs. An
association of anti-tuberculosis antibodies with decreased
severity of COVID-19 has been reported by Kovacic [5]
and Miller et al. [6]. Countries with a long-standing BCG
program had some degree of protection against COVID-19,
corroborating the finding of Escobar et al. [7] that every
10% increase in the BCG index was associated with a 10.4%
reduction in COVID-19 mortality. Taken together, the higher
burden of tuberculosis and pediatric mortality in the control
countries can be explained by the “hygiene hypothesis,”
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which relates to the decreasing incidence of infections in
Western countries, as identified by Stiemsma et al. [8].
Welliver [9] noted that temperature and the UV light index
were significant indicators, whereby colder temperatures
seemed to favor a high burden of COVID-19, similar to
the associations of temperature with influenza and other
respiratory viruses. However, further studies are needed
to confirm this finding. Population density seems to
have been a vital factor that differentiated the cases and
controls. The case countries/states had more than 3 times
the number of people living per square kilometer of land.
This is a logical result, since crowding leads to higher rates
of transmission of droplet infections. In countries with
lower population densities, Corburn et al. [10] pointed
out that most of the population lives in rural settings with
automatic distancing, whereas heavily urbanized areas
pose difficulties in implementing social distancing due to
the living environment.
It is of note that several of our indicators, including obesity,
stunting, and tobacco use, proved not to be statistically
significant. We suspected that the case countries/states
would primarily have cities with underground mass public
transit available, but our findings were insignificant.
Seventy percent (7 out of 10) of our case countries/states
and 51.7% (31 out of 60) of our controls had underground
mass public transit available, and this difference was not
statistically significant. Tobacco use and obesity, which are
risk factors for many diseases, were also not found to be
significant between the case and control countries/states.
Stunting, malaria incidence, and poverty index data were
not available for many developed countries. As malaria and
stunting are not major public health concerns in that part of
the world, these parameters are not rigorously documented.
Moreover, these countries have stronger economies and
have not been assigned a poverty index number, so this
variable was treated as missing data.

years of age, whereas the corresponding percentages in
Spain and the US are 19% and 16%, respectively. This factor
may have contributed to the high level of mortality in Italy,
but other factors are also likely to have played a role. The
contribution of population demographics to increased
COVID-19 mortality has been explored by Kontis et al. [12],
who showed a correlation with the elderly population
across different countries. Another possible explanation
posited by Islam et al. [13] is that the COVID-19 virus strains
present in Europe were deadlier than the North American
strains. A genome-wide association study of severe
COVID-19 patients conducted by Severe Covid-19 GWAS
Group et al. [14] identified a gene cluster on chromosome
3 as a risk locus for respiratory failure. The COVID-19
Host Genetics Initiative [15] reported that nearly 50% of
individuals in South Asia are carriers of this suspicous
region, while Zeberg and Paabo [16] identified that 16% of
people in Europe are carriers. Although the specific genes
contributing to the severity of COVID-19 remain elusive,
other contributors, including socioeconomic changes and
preexisitng conditions, may have contributed to the high
disparities in the death toll.

Strengths
We systematically explored 30 variables related to the life
sciences, including climate, population demographics, public
health indices, and infrastructure. The study employed a
holistic approach aiming to account for many risk factors. By
using mortality per population as the principal measure of
severity of the disease, 2 goals were achieved: first, the study
eliminated patients with mild disease and therefore focused
only on those who were a burden on the health system, and
second, a fair comparison was made between countries
with larger and smaller populations. The control countries
were matched based on population size for all dependent
variables. Lastly, all data were obtained from publicly
available, verifiable sources.

The Cases of Spain, Italy, and the United States
Our secondary analysis revealed that Italy and Spain had
much higher proportions of deaths among COVID-19
cases than that of the US (Figure 7). One explanation is
that the testing threshold for Spain and Italy was much
higher, increasing the likelihood of high-risk patients
testing positive. However, Roser et al. [11] reported that the
COVID-19 positivity rates of Spain, Italy, and the USA were
3% to 5%, 5% to 10%, and 10% to 20%, respectively. Another
explanation is that in Italy and Spain, a higher percentage
of the population is over 65 years of age than in the US.
A more detailed look at the individual country numbers
indicated that 23% of the population of Italy is over 65

70

Limitations
The study aimed to identify the top 10 countries and states
that were worst affected by COVID-19 in the early stage of the
pandemic. Many countries/states had a limited number of
laboratory polymerase chain reaction testing kits and were
unable to test a sufficient number of suspected individuals.
The case and control countries/states were identified based
on the COVID-19 mortality data from only March and April
2020; analyzing the spread of the virus in the following
months may yield different results regarding the top 10
countries/states. For 23 of the 30 variables, data were not
available for individual states of the USA and combined

https://doi.org/10.24171/j.phrp.2021.12.2.03
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data of the USA were used, leaving no differences across the
states. Furthermore, population-level data (not individual
data) were employed, which may have caused this study to
be affected by the ecological fallacy, which is an important
bias in studies involving population-level data collection.

Conclusion
The death toll following the first wave of the COVID-19
pandemic was affected by all 3 types of determinants
(environmental, host-related, and infrastucture-related).
We investigated various factors that potentially contributed
to the global discrepancy in mortality rates. Countries
implemented various control measures such as suspending
public transport and promoting physical isolation. Even as
the national emergency responses varied across countries,
significant impacts of key environmental, host-related, and
infrastructure-related determinants were identified. Our
results shine light on the epidemiological contributors to
variation in COVID-19 mortality. Our findings may guide future
researchers to investigate these parameters concerning
COVID-19 and help deduce factors related to COVID-19
preparedness for the second and third waves of the
pandemic. Actions to mitagate future global health threats
require identifying deficiencies in the existing health systems,
as well as improving coordination and implementation.

Additional Contributions
The authors would like to acknowledge Gaurav Patel, MD for his
contribution to the graphics of Figure 2.
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